Culver City-based ImmunityBio, Inc., a leading immunotherapy company, has announced that the U.S. Food and Drug ...

A new study published in AI in Precision Oncology examines the ability of large language models (LLMs) to rapidly extract ...

The researchers found that factors favoring chemoimmunotherapy included higher socioeconomic status, being uninsured, a more ...

Q4 2024 Earnings Call Transcript March 4, 2025 Compugen Ltd. misses on earnings expectations. Reported EPS is $-0.07 EPS, ...

BeiGene’s Tevimbra (tislelizumab-jsgr) has been approved by the US Food and Drug Administration (FDA) as part of a first-line ...

Esophageal squamous cell carcinoma accounts for approximately 90% of all esophageal cancer cases. Projections estimate that ...

Topline interim dataset from GALAXIES Lung-201 with >240 patients anticipated in 2Q25- Interim datasets from GALAXIES H&N-202 and TIG-006 HNSCC with ~200 patients anticipated in 2025- Completed ...

"I'm an experienced weight lifter, and I wanted to create a bumper-like cover for use with metal weight plates," said an inventor, from McKinleyville, Calif., "so I invented the PLATE PROTECTOR. My ...

Family and gender-based violence can have lasting impacts on physical and mental health and be at the root of public health issues, such as substance use, suicide and self-harm, anxiety, depression ...

The US Food and Drug Administration (FDA) has approved BeiGene’s Tevimbra (tislelizumab-jsgr) along with platinum-containing ...

Discover a study where results suggest trends towards overall survival and progression-free survival improvements with ...